The relative lymphocyte count predicts death in patients receiving implantable cardioverter defibrillators

Steve R. Ommen, Stephen C. Hammill, Raymond J Gibbons

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Although the survival benefit conveyed by the automatic defibrillator has been well established for several subsets of patients, some patients who receive the device still die early. The relative lymphocyte count (%L), a portion of the white blood cell count differential, which is decreased in states of excess systemic stress, has prognostic value in patients with coronary artery disease and advanced heart failure. This study assessed the association of %L with survival in patients receiving automatic defibrillators. A total of 136 consecutive patients (81% men; mean age 64 ± 12 years) who were using automatic defibrillators were followed for 29.6 months. The mean ejection fraction was 0.36 ± 0.17, the mean %L was 22.7 ± 8%, and 55 (40%) patients had decreased %L (< 20.3%). There were 20 deaths, for a 4-year survival of 71.5%. The association of %L with time to death was assessed by Cox proportional hazards analysis. Ejection fraction (P = 0.005), %L (P = 0.01), and diagnosis (P = 0.03) were independently associated with time to death on multivariate analysis. One-year and 4-year survival rates were 93% and 54%, respectively, for the 55 patients with abnormal %L, compared with 99% and 84%, respectively, for the 81 with normal %L (P = 0.03). This suggests that the %L is a readily accessible prognostic marker in patients using automatic defibrillators. This association is independent of age, sex, diagnosis, and ejection fraction.

Original languageEnglish (US)
Pages (from-to)1424-1428
Number of pages5
JournalPACE - Pacing and Clinical Electrophysiology
Volume25
Issue number10
StatePublished - Oct 1 2002

Fingerprint

Implantable Defibrillators
Lymphocyte Count
Defibrillators
Survival
Leukocyte Count
Coronary Artery Disease
Multivariate Analysis
Survival Rate
Heart Failure
Equipment and Supplies

Keywords

  • Cardiovascular diseases
  • Defibrillation
  • Lymphocytes
  • Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The relative lymphocyte count predicts death in patients receiving implantable cardioverter defibrillators. / Ommen, Steve R.; Hammill, Stephen C.; Gibbons, Raymond J.

In: PACE - Pacing and Clinical Electrophysiology, Vol. 25, No. 10, 01.10.2002, p. 1424-1428.

Research output: Contribution to journalArticle

@article{c5063c3c22c446129e3f946f0747ca3d,
title = "The relative lymphocyte count predicts death in patients receiving implantable cardioverter defibrillators",
abstract = "Although the survival benefit conveyed by the automatic defibrillator has been well established for several subsets of patients, some patients who receive the device still die early. The relative lymphocyte count ({\%}L), a portion of the white blood cell count differential, which is decreased in states of excess systemic stress, has prognostic value in patients with coronary artery disease and advanced heart failure. This study assessed the association of {\%}L with survival in patients receiving automatic defibrillators. A total of 136 consecutive patients (81{\%} men; mean age 64 ± 12 years) who were using automatic defibrillators were followed for 29.6 months. The mean ejection fraction was 0.36 ± 0.17, the mean {\%}L was 22.7 ± 8{\%}, and 55 (40{\%}) patients had decreased {\%}L (< 20.3{\%}). There were 20 deaths, for a 4-year survival of 71.5{\%}. The association of {\%}L with time to death was assessed by Cox proportional hazards analysis. Ejection fraction (P = 0.005), {\%}L (P = 0.01), and diagnosis (P = 0.03) were independently associated with time to death on multivariate analysis. One-year and 4-year survival rates were 93{\%} and 54{\%}, respectively, for the 55 patients with abnormal {\%}L, compared with 99{\%} and 84{\%}, respectively, for the 81 with normal {\%}L (P = 0.03). This suggests that the {\%}L is a readily accessible prognostic marker in patients using automatic defibrillators. This association is independent of age, sex, diagnosis, and ejection fraction.",
keywords = "Cardiovascular diseases, Defibrillation, Lymphocytes, Mortality",
author = "Ommen, {Steve R.} and Hammill, {Stephen C.} and Gibbons, {Raymond J}",
year = "2002",
month = "10",
day = "1",
language = "English (US)",
volume = "25",
pages = "1424--1428",
journal = "PACE - Pacing and Clinical Electrophysiology",
issn = "0147-8389",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - The relative lymphocyte count predicts death in patients receiving implantable cardioverter defibrillators

AU - Ommen, Steve R.

AU - Hammill, Stephen C.

AU - Gibbons, Raymond J

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Although the survival benefit conveyed by the automatic defibrillator has been well established for several subsets of patients, some patients who receive the device still die early. The relative lymphocyte count (%L), a portion of the white blood cell count differential, which is decreased in states of excess systemic stress, has prognostic value in patients with coronary artery disease and advanced heart failure. This study assessed the association of %L with survival in patients receiving automatic defibrillators. A total of 136 consecutive patients (81% men; mean age 64 ± 12 years) who were using automatic defibrillators were followed for 29.6 months. The mean ejection fraction was 0.36 ± 0.17, the mean %L was 22.7 ± 8%, and 55 (40%) patients had decreased %L (< 20.3%). There were 20 deaths, for a 4-year survival of 71.5%. The association of %L with time to death was assessed by Cox proportional hazards analysis. Ejection fraction (P = 0.005), %L (P = 0.01), and diagnosis (P = 0.03) were independently associated with time to death on multivariate analysis. One-year and 4-year survival rates were 93% and 54%, respectively, for the 55 patients with abnormal %L, compared with 99% and 84%, respectively, for the 81 with normal %L (P = 0.03). This suggests that the %L is a readily accessible prognostic marker in patients using automatic defibrillators. This association is independent of age, sex, diagnosis, and ejection fraction.

AB - Although the survival benefit conveyed by the automatic defibrillator has been well established for several subsets of patients, some patients who receive the device still die early. The relative lymphocyte count (%L), a portion of the white blood cell count differential, which is decreased in states of excess systemic stress, has prognostic value in patients with coronary artery disease and advanced heart failure. This study assessed the association of %L with survival in patients receiving automatic defibrillators. A total of 136 consecutive patients (81% men; mean age 64 ± 12 years) who were using automatic defibrillators were followed for 29.6 months. The mean ejection fraction was 0.36 ± 0.17, the mean %L was 22.7 ± 8%, and 55 (40%) patients had decreased %L (< 20.3%). There were 20 deaths, for a 4-year survival of 71.5%. The association of %L with time to death was assessed by Cox proportional hazards analysis. Ejection fraction (P = 0.005), %L (P = 0.01), and diagnosis (P = 0.03) were independently associated with time to death on multivariate analysis. One-year and 4-year survival rates were 93% and 54%, respectively, for the 55 patients with abnormal %L, compared with 99% and 84%, respectively, for the 81 with normal %L (P = 0.03). This suggests that the %L is a readily accessible prognostic marker in patients using automatic defibrillators. This association is independent of age, sex, diagnosis, and ejection fraction.

KW - Cardiovascular diseases

KW - Defibrillation

KW - Lymphocytes

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=0036801728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036801728&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 1424

EP - 1428

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - 10

ER -